사나라메드테크 (SMTI) 주가

사나라메드테크(SMTI)는 NASDAQ에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $35.07 (+0.26%), 시가총액 $0.20B, PER (주가수익비율) 360.67, 52주 최저~최고 $16.34 ~ $35.75.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingro

핵심 지표

• 현재가: $35.07 (+0.26%)
• 시가총액: $0.20B
• PER (주가수익비율): 360.67
• 52주 최저~최고: $16.34 ~ $35.75
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NASDAQ

사나라메드테크의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

사나라메드테크 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 28.40
• 순이익률: -0.31%
• 영업이익률: 0.10%

자주 묻는 질문